Aller au contenu principal
Profil bibliographique

Hayam A. Alwabsi

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

30Publications signalées
44Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Enzyme-mediated dye degradationComputational Drug Discovery MethodsMicrobial bioremediation and biosurfactantsSynthesis and biological activityEnzyme Catalysis and Immobilization

Les publications récentes

2026 article OpenAlex

Structure activity relationship-guided scaffold hopping for identification of novel thiadiazole derivatives as potent SARS-CoV-2 Mpro inhibitors

Maher S. Alwethaynani, Khaled Alzhrani, Hina Sarfraz, Tahir Ali Chohan et autres

Abstract The ongoing COVID-19 pandemic has presented enormous challenges to worldwide healthcare systems, and effective therapeutic strategies must accompany mass vaccination efforts. In this context, Mpro (the main protease of SARS-CoV-2) is arguably one of the most promising molecular targets for antiviral …

sa, pk (code pays fourni par la source)

0 citations Zeitschrift für Naturforschung C
2026 article OpenAlex

Elucidating the biodegradation potential of Nudix hydrolase from Bacillus paranthracis via different approaches

Muhammad Huzaifa Naveed, Nimra Hanif, Minahil Zahid, Muhammad Asjad Haseeb et autres

MBBL1 was investigated using in silico approaches. Polyfluoroalkyl substances (PFAS) are persistent environmental contaminants associated with serious health and ecological risks because of their stable chemical nature and strong resistance to breakdown. The enzyme sequence was retrieved from NCBI (Accession No. MFQ6175622.1), …

pk, sa (code pays fourni par la source)

0 citations Zeitschrift für Naturforschung C
2026 article OpenAlex

Optimization of 1-(Difluoromethyl)-6-(1H2 Imidazol-5-yl) Imidazo[1,5-a] Pyrazin-8(7H)-One Frameworks as Promising Cholinesterase Inhibitors for Treating Alzheimer’s Disease

Hanan M. Alharbi, Nawal Al‐Hoshani, Hina Sarfraz, Abubakar Sadiq Bello et autres

Acetylcholinesterase (AChE) and Butyrylcholinesterase (BuChE) inhibitors are used to increase acetylcholine levels in current symptomatic treatments for Alzheimer’s disease (AD), which is still the most common neurodegenerative illness. Through the synthesis and thorough assessment of a novel series of Imidazo-pyrazinone derivatives (8a–8l), …

sa, hk, Nigéria, us, pk (code pays fourni par la source)

3 citations Journal of Computational Biophysics and Chemistry

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.